• 1. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 4. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 5. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182

Introduction to (2-Chloro-thiazol-5-ylmethyl)-piperidin-4-ylmethyl-amine Hydrochloride (CAS No. 1261234-99-4)

(2-Chloro-thiazol-5-ylmethyl)-piperidin-4-ylmethyl-amine hydrochloride (CAS No. 1261234-99-4) is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has shown promising potential in various therapeutic applications, particularly in the treatment of neurological disorders and cancer.

The chemical structure of (2-Chloro-thiazol-5-ylmethyl)-piperidin-4-ylmethyl-amine hydrochloride consists of a piperidine ring linked to a thiazole moiety through a methylene bridge, with a chlorine atom substituting one of the thiazole ring's carbon atoms. The presence of the hydrochloride salt form enhances its solubility and stability, making it suitable for various pharmaceutical formulations.

Recent research studies have highlighted the multifaceted biological activities of this compound. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that (2-Chloro-thiazol-5-ylmethyl)-piperidin-4-ylmethyl-amine hydrochloride exhibits potent antioxidant properties, which can help mitigate oxidative stress and inflammation. These properties are particularly relevant in the context of neurodegenerative diseases such as Alzheimer's and Parkinson's disease, where oxidative stress plays a significant role in disease progression.

Moreover, this compound has shown anti-cancer potential in preclinical studies. Research conducted at the National Cancer Institute revealed that (2-Chloro-thiazol-5-ylmethyl)-piperidin-4-ylmethyl-amine hydrochloride can selectively inhibit the growth of cancer cells while sparing normal cells. The mechanism of action is believed to involve the modulation of key signaling pathways involved in cell proliferation and apoptosis.

In addition to its therapeutic applications, (2-Chloro-thiazol-5-ylmethyl)-piperidin-4-ylmethyl-amine hydrochloride has been explored for its pharmacokinetic properties. Studies have shown that it has favorable absorption, distribution, metabolism, and excretion (ADME) profiles, which are crucial for developing effective drug candidates. The compound's ability to cross the blood-brain barrier makes it particularly suitable for treating central nervous system disorders.

The synthesis of (2-Chloro-thiazol-5-ylmethyl)-piperidin-4-ylmethyl-amine hydrochloride involves several well-defined chemical reactions. Typically, the synthesis begins with the formation of the thiazole ring followed by the introduction of the chlorine atom and the piperidine moiety. The final step involves the formation of the hydrochloride salt to enhance solubility and stability. This synthetic route is highly reproducible and can be scaled up for industrial production.

Despite its promising potential, further research is needed to fully understand the safety and efficacy of (2-Chloro-thiazol-5-ylmethyl)-piperidin-4-ylmethyl-amine hydrochloride. Clinical trials are currently underway to evaluate its therapeutic effects in human subjects. These trials aim to assess the compound's pharmacological profile, including its safety, tolerability, and efficacy in treating specific diseases.

In conclusion, (2-Chloro-thiazol-5-ylmethyl)-piperidin-4-y lmethylamine hydrochloride (CAS No. 1261234-99-4) is a promising compound with a wide range of potential applications in medicine. Its unique chemical structure and biological activities make it an attractive candidate for further development in both academic research and pharmaceutical industries. As more data becomes available from ongoing studies and clinical trials, it is likely that this compound will play an increasingly important role in advancing therapeutic options for various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)